| 1 |
Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022 [J]. J Natl Cancer Cent, 2024, 4(1): 47-53.
|
| 2 |
赵瑞芝, 罗京伟, 肖建平, 等. 肺转移瘤大分割精准放疗临床疗效分析 [J]. 中华放射肿瘤学杂志, 2020, 29(8): 639-643.
|
| 3 |
Hellman S, Weichselbaum RR. Oligometastases [J]. J Clin Oncol, 1995, 13(1): 8-10.
|
| 4 |
Iyengar P, Wardak Z, Gerber DE, et al. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial [J]. JAMA Oncology, 2018, 4(1): e173501.
|
| 5 |
Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial [J]. Lancet, 2019, 393(10185): 2051-2058.
|
| 6 |
Gomez D R, Tang C, Zhang J, et al. Local consolidative therapy vs maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase Ⅱ, randomized study [J]. J Clin Oncol, 2019, 37(18): 1558-1565.
|
| 7 |
Tsai CJ, Yang JT, Shaverdian N, et al. Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (consolidative use of radiotherapy to block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study [J]. Lancet, 2024, 403(10422): 171-182.
|
| 8 |
Iyengar P, Hu C, Gomez D, et al. NRG-LU002: randomized phase Ⅱ/Ⅲ trial of maintenance systemic therapy versus local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC) [J]. J Clin Oncol, 2024, 42(16_suppl): 8506-8506.
|
| 9 |
Ricco A, Davis J, Rate W, et al. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient registry's experience [J]. Radiat Oncol, 2017, 12(1): 35.
|
| 10 |
Kobiela J, Spychalski P, Marvaso G, et al. Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: systematic review [J]. Crit Rev Oncol Hematol, 2018, 129: 91-101.
|
| 11 |
Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase Ⅱ randomized trial [J]. J Clin Oncol, 2020, 38(25): 2830-2838.
|
| 12 |
Nuyttens JJ, van der Voort van Zyp NC, Verhoef C, et al. Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study [J]. Int J Radiat Oncol Biol Phys, 2015, 91(2): 337-343.
|
| 13 |
Petty WJ, Urbanic JJ, Ahmed T, et al. Long-term outcomes of a phase 2 trial of chemotherapy with consolidative radiation therapy for oligometastatic non-small cell lung cancer [J]. Int J Radiat Oncol Biol Phys, 2018, 102(3): 527-535.
|
| 14 |
Mielgo-Rubio X, Garde-Noguera J, Juan O, et al. Stereotactic body radiation therapy: a good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study [J]. World J Clin Oncol, 2020, 11(12): 983-989.
|
| 15 |
Chen HJ, Tu HY, Hu Y, et al. A phase Ⅱ trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001) [J]. J Hematol Oncol, 2025, 18(1): 3.
|
| 16 |
Chen M, Ma H, Du X, et al. 698 a phase 2 study of durvalumab combined with chemotherapy and stereotactic body radiotherapy (SBRT) in patients with oligometastatic non-small cell lung cancer (NSCLC) (SABRCURE trial)[C]//Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd, 2022: A729-A729.
|
| 17 |
宋丽萍, 赵璨. 晚期EGFR突变NSCLC患者单药与联合化疗或抗血管生成药物治疗效果的真实世界比较分析[J/OL]. 中华临床医师杂志(电子版), 2025, 19(1): 1.
|
| 18 |
Marks LB, Bentzen SM, Deasy JO, et al. Radiation dose-volume effects in the lung [J]. Int J Radiat Oncol Biol Phys, 2010, 76(3 Suppl): S70-76.
|
| 19 |
Farr KP, Khalil AA, Grau C. Patient-reported lung symptoms and quality of life before and after radiation therapy for non-small cell lung cancer: correlation with radiation pneumonitis and functional imaging [J]. Acta Oncol, 2019, 58(10): 1523-1527.
|
| 20 |
张永彤, 王春春, 黄芳, 等. 肺癌放射治疗造成急性放射性肺炎的临床治疗研究 [J]. 中国全科医学, 2021, 24(s01): 103-105.
|
| 21 |
营养评估在预测老年食管癌患者放疗及同步放化疗急性不良事件中的作用[EB/OL]. 2026-02-28.
|
| 22 |
Zhou Z, Song X, Wu A, et al. Pulmonary emphysema is a risk factor for radiation pneumonitis in NSCLC patients with squamous cell carcinoma after thoracic radiation therapy [J]. Sci Rep, 2017, 7(1): 2748.
|